| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 26/03/2015 | 15:12 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 17/02/2015 | 18:10 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 04/11/2013 | 20:23 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 30/10/2013 | 11:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 29/10/2013 | 00:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 20:32 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 20:29 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 18:55 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 24/10/2013 | 15:47 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 15/10/2013 | 15:23 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 25/09/2013 | 15:05 | Marketwired | Stellar Biotechnologies Appoints Tessie Che, Ph.D. to Board of Directors | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 18/09/2013 | 22:53 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 18/09/2013 | 22:32 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 13/08/2013 | 03:45 | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Optimer Pharmaceuticals, Inc. | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 12/08/2013 | 23:40 | Business Wire | SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Optimer Pharmaceuticals, Inc. | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 07/08/2013 | 20:47 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 05/08/2013 | 23:58 | PR Newswire (US) | SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Optimer Pharmaceuticals, Inc. - OPTR | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 01/08/2013 | 21:12 | Business Wire | Investigations into Proposed Buyouts of Optimer Pharmaceuticals, Inc., Trius Therapeutics, Inc. & Maidenform Brands, Inc. Ann... | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 01/08/2013 | 18:41 | Edgar (US Regulatory) | Mutual Fund Summary Prospectus (497k) | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 01/08/2013 | 17:32 | PR Newswire (US) | OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Opt... | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 01/08/2013 | 16:50 | PR Newswire (US) | Ryan & Maniskas, LLP Announces Investigation of Optimer Pharmaceuticals, Inc. | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 01/08/2013 | 14:00 | Business Wire | Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Optimer Pharmaceuticals, Inc. Over the Proposed... | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 01/08/2013 | 14:00 | PR Newswire (US) | Optimer Reports Second Quarter 2013 Financial Results | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 01/08/2013 | 03:36 | Business Wire | OPTIMER PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Optim... | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 31/07/2013 | 23:36 | Business Wire | OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Opti... | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 31/07/2013 | 22:13 | Business Wire | Milberg Announces Investigation of Unfair Low Price In Cubist’s Acquisition of Optimer | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 31/07/2013 | 21:22 | PR Newswire (US) | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Optimer Pharmaceuticals, Inc. - OPTR | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 31/07/2013 | 20:01 | Business Wire | Rigrodsky & Long, P.A. Announces Investigation Of Optimer Pharmaceuticals, Inc. Buyout | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 31/07/2013 | 18:46 | Business Wire | Finkelstein Thompson LLP Announces Investigation of Optimer Pharmaceuticals, Inc. Buyout | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |
| 31/07/2013 | 17:42 | Business Wire | Optimer Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Sale of Optimer to Cubist | NASDAQ:OPTR | Optimer Pharmaceuticals, Inc. (MM) |